A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin

Neurobiology of Aging

Volumn 37, Issue , 2016, Pages 208.e1-208.e9

  Deming, Yuetiva ^a   Xia, Jian ^a   Cai, Yefei ^a   Lord, Jenny ^a   Holmans, Peter ^b   Bertelsen, Sarah ^a   Holtzman, David ^a   Morris, John C ^a   Bales, Kelly ^c   Pickering, Eve H ^c   Kauwe, John ^d   Goate, Alison ^a   Cruchaga, Carlos ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^c PFIZER INC   (United States)

^d BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; APOE; Cerebrospinal fluid; Clusterin; Gene ontology; Immune response

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; CLUSTERIN; INTERLEUKIN 6; TAU PROTEIN; APOLIPOPROTEIN E4; BIOLOGICAL MARKER;

AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD LEVEL; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENDOPHENOTYPE; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; ONTOLOGY; PATHOGENESIS; WOUND HEALING; BLOOD; CEREBROSPINAL FLUID; GENE ONTOLOGY; GENETICS; GENOME-WIDE ASSOCIATION STUDY; IMMUNITY; IMMUNOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BIOMARKERS; CLUSTERIN; ENDOPHENOTYPES; FEMALE; GENE ONTOLOGY; GENOME-WIDE ASSOCIATION STUDY; HUMANS; IMMUNITY; MALE; NERVE DEGENERATION; WOUND HEALING;

EID: 85015043550     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2015.09.009     Document Type: Article

References (60)

1. Ashburner, M., Ball, C.A., Blake, J.A., Botstein, D., Butler, H., Cherry, J.M., Davis, A.P., Dolinski, K., Dwight, S.S., Eppig, J.T., Harris, M.A., Hill, D.P., Issel-Tarver, L., Kasarskis, A., Lewis, S., Matese, J.C., Richardson, J.E., Ringwald, M., Rubin, G.M., Sherlock, G., Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25 (2000), 25–29.
2. Browning, B.L., Browning, S.R., Efficient multilocus association testing for whole genome association studies using localized haplotype clustering. Genet. Epidemiol. 31 (2007), 365–375.
3. Bult, C.J., Eppig, J.T., Kadin, J.A., Richardson, J.E., Blake, J.A., Mouse genome database Group. The Mouse Genome Database (MGD): mouse biology and model systems. Nucleic Acids Res. 36:Database issue (2008), D724–D728.
4. Chang, C.C., Chow, C.C., Tellier, L.C., Vattikuti, S., Purcell, S.M., Lee, J.J., Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience, 4, 2015, 7.
5. Croft, D., Mundo, A.F., Haw, R., Milacic, M., Weiser, J., Wu, G., Caudy, M., Garapati, P., Gillespie, M., Kamdar, M.R., Jassal, B., Jupe, S., Matthews, L., May, B., Palatnik, S., Rothfels, K., Shamovsky, V., Song, H., Williams, M., Birney, E., Hermjakob, H., Stein, L., D'Eustachio, P., The reactome pathway knowledgebase. Nucleic Acids Res. 42:Database issue (2014), D472–D477.
6. Cruchaga, C., Graff, C., Chiang, H.H., Wang, J., Hinrichs, A.L., Spiegel, N., Bertelsen, S., Mayo, K., Norton, J.B., Morris, J.C., Goate, A., Association of TMEM106B gene polymorphism with age at onset in granulin mutation carriers and plasma granulin protein levels. Arch. Neurol. 68 (2011), 581–586.
7. Cruchaga, C., Kauwe, J.S., Harari, O., Jin, S.C., Cai, Y., Karch, C.M., Benitez, B.A., Jeng, A.T., Skorupa, T., Carrell, D., Bertelsen, S., Bailey, M., McKean, D., Shulman, J.M., De Jager, P.L., Chibnik, L., Bennett, D.A., Arnold, S.E., Harold, D., Sims, R., Gerrish, A., Williams, J., Van Deerlin, V.M., Lee, V.M., Shaw, L.M., Trojanowski, J.Q., Haines, J.L., Mayeux, R., Pericak-Vance, M.A., Farrer, L.A., Schellenberg, G.D., Peskind, E.R., Galasko, D., Fagan, A.M., Holtzman, D.M., Morris, J.C. Consortium, G Alzheimer's Disease Neuroimaging I., Alzheimer Disease Genetic, C, Goate, A.M., GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease. Neuron 78 (2013), 256–268.
8. Cruchaga, C., Kauwe, J.S., Nowotny, P., Bales, K., Pickering, E.H., Mayo, K., Bertelsen, S., Hinrichs, A. Alzheimer's Disease Neuroimaging, I, Fagan, A.M., Holtzman, D.M., Morris, J.C., Goate, A.M., Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease. Hum. Mol. Genet. 21 (2012), 4558–4571.
9. Dayem Ullah, A.Z., Lemoine, N.R., Chelala, C., SNPnexus: a web server for functional annotation of novel and publicly known genetic variants (2012 update). Nucleic Acids Res. 40:Web Server issue (2012), W65–W70.
10. de Jong, D., Jansen, R.W., Kremer, B.P., Verbeek, M.M., Cerebrospinal fluid amyloid beta42/phosphorylated tau ratio discriminates between Alzheimer's disease and vascular dementia. J. Gerontol. A Biol. Sci. Med. Sci. 61 (2006), 755–758.
11. DeMattos, R.B., Cirrito, J.R., Parsadanian, M., May, P.C., O'Dell, M.A., Taylor, J.W., Harmony, J.A., Aronow, B.J., Bales, K.R., Paul, S.M., Holtzman, D.M., ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo. Neuron 41 (2004), 193–202.
12. Desikan, R.S., Thompson, W.K., Holland, D., Hess, C.P., Brewer, J.B., Zetterberg, H., Blennow, K., Andreassen, O.A., McEvoy, L.K., Hyman, B.T., Dale, A.M., Alzheimer's Disease Neuroimaging Initiative Group. The role of clusterin in amyloid-beta-associated neurodegeneration. JAMA Neurol. 71 (2014), 180–187.
13. de Silva, H.V., Harmony, J.A., Stuart, W.D., Gil, C.M., Robbins, J., Apolipoprotein J: structure and tissue distribution. Biochemistry 29 (1990), 5380–5389.
14. Devauchelle, V., Essabbani, A., De Pinieux, G., Germain, S., Tourneur, L., Mistou, S., Margottin-Goguet, F., Anract, P., Migaud, H., Le Nen, D., Lequerre, T., Saraux, A., Dougados, M., Breban, M., Fournier, C., Chiocchia, G., Characterization and functional consequences of underexpression of clusterin in rheumatoid arthritis. J. Immunol. 177 (2006), 6471–6479.
15. Ebihara, N., Matsuda, A., Nakamura, S., Matsuda, H., Murakami, A., Role of the IL-6 classic- and trans-signaling pathways in corneal sterile inflammation and wound healing. Invest. Ophthalmol. Vis. Sci. 52 (2011), 8549–8557.
16. Fagan, A.M., Mintun, M.A., Mach, R.H., Lee, S.Y., Dence, C.S., Shah, A.R., LaRossa, G.N., Spinner, M.L., Klunk, W.E., Mathis, C.A., DeKosky, S.T., Morris, J.C., Holtzman, D.M., Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Ann. Neurol. 59 (2006), 512–519.
17. Fagan, A.M., Roe, C.M., Xiong, C., Mintun, M.A., Morris, J.C., Holtzman, D.M., Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults. Arch. Neurol. 64 (2007), 343–349.
18. Ghiso, J., Matsubara, E., Koudinov, A., Choi-Miura, N.H., Tomita, M., Wisniewski, T., Frangione, B., The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex. Biochem. J. 293:Pt 1 (1993), 27–30.
19. Harari, O., Cruchaga, C., Kauwe, J.S., Ainscough, B.J., Bales, K., Pickering, E.H., Bertelsen, S., Fagan, A.M., Holtzman, D.M., Morris, J.C., Goate, A.M., Alzheimer's Disease Neuroimaging, I. Phosphorylated tau-Abeta42 ratio as a continuous trait for biomarker discovery for early-stage Alzheimer's disease in multiplex immunoassay panels of cerebrospinal fluid. Biol. Psychiatry 75 (2014), 723–731.
20. Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M.L., Pahwa, J.S., Moskvina, V., Dowzell, K., Williams, A., Jones, N., Thomas, C., Stretton, A., Morgan, A.R., Lovestone, S., Powell, J., Proitsi, P., Lupton, M.K., Brayne, C., Rubinsztein, D.C., Gill, M., Lawlor, B., Lynch, A., Morgan, K., Brown, K.S., Passmore, P.A., Craig, D., McGuinness, B., Todd, S., Holmes, C., Mann, D., Smith, A.D., Love, S., Kehoe, P.G., Hardy, J., Mead, S., Fox, N., Rossor, M., Collinge, J., Maier, W., Jessen, F., Schurmann, B., Heun, R., van den Bussche, H., Heuser, I., Kornhuber, J., Wiltfang, J., Dichgans, M., Frolich, L., Hampel, H., Hull, M., Rujescu, D., Goate, A.M., Kauwe, J.S., Cruchaga, C., Nowotny, P., Morris, J.C., Mayo, K., Sleegers, K., Bettens, K., Engelborghs, S., De Deyn, P.P., Van Broeckhoven, C., Livingston, G., Bass, N.J., Gurling, H., McQuillin, A., Gwilliam, R., Deloukas, P., Al-Chalabi, A., Shaw, C.E., Tsolaki, M., Singleton, A.B., Guerreiro, R., Muhleisen, T.W., Nothen, M.M., Moebus, S., Jockel, K.H., Klopp, N., Wichmann, H.E., Carrasquillo, M.M., Pankratz, V.S., Younkin, S.G., Holmans, P.A., O'Donovan, M., Owen, M.J., Williams, J., Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat. Genet. 41 (2009), 1088–1093.
21. Harris, M.A., Clark, J., Ireland, A., Lomax, J., Ashburner, M., Foulger, R., Eilbeck, K., Lewis, S., Marshall, B., Mungall, C., Richter, J., Rubin, G.M., Blake, J.A., Bult, C., Dolan, M., Drabkin, H., Eppig, J.T., Hill, D.P., Ni, L., Ringwald, M., Balakrishnan, R., Cherry, J.M., Christie, K.R., Costanzo, M.C., Dwight, S.S., Engel, S., Fisk, D.G., Hirschman, J.E., Hong, E.L., Nash, R.S., Sethuraman, A., Theesfeld, C.L., Botstein, D., Dolinski, K., Feierbach, B., Berardini, T., Mundodi, S., Rhee, S.Y., Apweiler, R., Barrell, D., Camon, E., Dimmer, E., Lee, V., Chisholm, R., Gaudet, P., Kibbe, W., Kishore, R., Schwarz, E.M., Sternberg, P., Gwinn, M., Hannick, L., Wortman, J., Berriman, M., Wood, V., de la Cruz, N., Tonellato, P., Jaiswal, P., Seigfried, T., White, R., Gene Ontology, C., The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res. 32:Database issue (2004), D258–D261.
22. Holmans, P., Green, E.K., Pahwa, J.S., Ferreira, M.A., Purcell, S.M., Sklar, P., Wellcome Trust Case-Control, C, Owen, M.J., O'Donovan, M.C., Craddock, N., Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. Am. J. Hum. Genet. 85 (2009), 13–24.
23. Howlett, D.R., Hortobagyi, T., Francis, P.T., Clusterin associates specifically with Abeta40 in Alzheimer's disease brain tissue. Brain Pathol. 23 (2013), 623–632.
24. Hull, M., Fiebich, B.L., Lieb, K., Strauss, S., Berger, S.S., Volk, B., Bauer, J., Interleukin-6-associated inflammatory processes in Alzheimer's disease: new therapeutic options. Neurobiol. Aging 17 (1996), 795–800.
25. Imhof, A., Charnay, Y., Vallet, P.G., Aronow, B., Kovari, E., French, L.E., Bouras, C., Giannakopoulos, P., Sustained astrocytic clusterin expression improves remodeling after brain ischemia. Neurobiol. Dis. 22 (2006), 274–283.
26. Johnson, A.D., Handsaker, R.E., Pulit, S.L., Nizzari, M.M., O'Donnell, C.J., de Bakker, P.I., SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 24:24 (2008), 2938–2939.
27. Kamburov, A., Pentchev, K., Galicka, H., Wierling, C., Lehrach, H., Herwig, R., ConsensusPathDB: toward a more complete picture of cell biology. Nucleic Acids Res. 39:Database issue (2011), D712–D717.
28. Kanehisa, M., Goto, S., Sato, Y., Furumichi, M., Tanabe, M., KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res. 40:Database issue (2012), D109–D114.
29. Karolchik, D., Hinrichs, A.S., Furey, T.S., Roskin, K.M., Sugnet, C.W., Haussler, D., Kent, W.J., The UCSC Table Browser data retrieval tool. Nucleic Acids Res. 32:Database issue (2004), D493–D496.
30. Kauwe, J.S., Bailey, M.H., Ridge, P.G., Perry, R., Wadsworth, M.E., Hoyt, K.L., Staley, L.A., Karch, C.M., Harari, O., Cruchaga, C., Ainscough, B.J., Bales, K., Pickering, E.H., Bertelsen, S., Alzheimer's Disease Neuroimaging, I, Fagan, A.M., Holtzman, D.M., Morris, J.C., Goate, A.M., Genome-wide association study of CSF levels of 59 Alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation. PLoS Genet., 10, 2014, e1004758.
31. Kent, W.J., Haussler, D., Assembly of the working draft of the human genome with GigAssembler. Genome Res. 11 (2001), 1541–1548.
32. Kent, W.J., Sugnet, C.W., Furey, T.S., Roskin, K.M., Pringle, T.H., Zahler, A.M., Haussler, D., The human genome browser at UCSC. Genome Res. 12 (2002), 996–1006.
33. Kim, N., Choi, W.S., Proapoptotic role of nuclear clusterin in brain. Anat. Cell Biol. 44 (2011), 169–175.
34. Kimura, K., Asami, K., Yamamoto, M., Effect of heat shock treatment on the production of variant testosterone-repressed prostate message-2 (TRPM-2) mRNA in culture cells. Cell Biochem. Funct. 15 (1997), 251–257.
35. Lambert, J.C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M.J., Tavernier, B., Letenneur, L., Bettens, K., Berr, C., Pasquier, F., Fievet, N., Barberger-Gateau, P., Engelborghs, S., De Deyn, P., Mateo, I., Franck, A., Helisalmi, S., Porcellini, E., Hanon, O., European Alzheimer's Disease Initiative, I, de Pancorbo, M.M., Lendon, C., Dufouil, C., aillard, C., Leveillard, T., Alvarez, V., Bosco, P., Mancuso, M., Panza, F., Nacmias, B., Bossu, P., Piccardi, P., Annoni, G., Seripa, D., Galimberti, D., Hannequin, D., Licastro, F., Soininen, H., Ritchie, K., Blanche, H., Dartigues, J.F., Tzourio, C., Gut, I., Van Broeckhoven, C., Alperovitch, A., Lathrop, M., Amouyel, P., Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet. 41 (2009), 1094–1099.
36. Lambert, J.C., Ibrahim-Verbaas, C.A., Harold, D., Naj, A.C., Sims, R., Bellenguez, C., DeStafano, A.L., Bis, J.C., Beecham, G.W., Grenier-Boley, B., Russo, G., Thorton-Wells, T.A., Jones, N., Smith, A.V., Chouraki, V., Thomas, C., Ikram, M.A., Zelenika, D., Vardarajan, B.N., Kamatani, Y., Lin, C.F., Gerrish, A., Schmidt, H., Kunkle, B., Dunstan, M.L., Ruiz, A., Bihoreau, M.T., Choi, S.H., Reitz, C., Pasquier, F., Cruchaga, C., Craig, D., Amin, N., Berr, C., Lopez, O.L., De Jager, P.L., Deramecourt, V., Johnston, J.A., Evans, D., Lovestone, S., Letenneur, L., Moron, F.J., Rubinsztein, D.C., Eiriksdottir, G., Sleegers, K., Goate, A.M., Fievet, N., Huentelman, M.W., Gill, M., Brown, K., Kamboh, M.I., Keller, L., Barberger-Gateau, P., McGuiness, B., Larson, E.B., Green, R., Myers, A.J., Dufouil, C., Todd, S., Wallon, D., Love, S., Rogaeva, E., Gallacher, J., St George-Hyslop, P., Clarimon, J., Lleo, A., Bayer, A., Tsuang, D.W., Yu, L., Tsolaki, M., Bossu, P., Spalletta, G., Proitsi, P., Collinge, J., Sorbi, S., Sanchez-Garcia, F., Fox, N.C., Hardy, J., Deniz Naranjo, M.C., Bosco, P., Clarke, R., Brayne, C., Galimberti, D., Mancuso, M., Matthews, F. European Alzheimer's Disease, I. Genetic, Environmental Risk in Alzheimer's, D. Alzheimer's Disease Genetic, C. Cohorts for, H., Aging Research in Genomic, E., Moebus, S., Mecocci, P., Del Zompo, M., Maier, W., Hampel, H., Pilotto, A., Bullido, M., Panza, F., Caffarra, P., Nacmias, B., Gilbert, J.R., Mayhaus, M., Lannefelt, L., Hakonarson, H., Pichler, S., Carrasquillo, M.M., Ingelsson, M., Beekly, D., Alvarez, V., Zou, F., Valladares, O., Younkin, S.G., Coto, E., Hamilton-Nelson, K.L., Gu, W., Razquin, C., Pastor, P., Mateo, I., Owen, M.J., Faber, K.M., Jonsson, P.V., Combarros, O., O'Donovan, M.C., Cantwell, L.B., Soininen, H., Blacker, D., Mead, S., Mosley, T.H. Jr., Bennett, D.A., Harris, T.B., Fratiglioni, L., Holmes, C., de Bruijn, R.F., Passmore, P., Montine, T.J., Bettens, K., Rotter, J.I., Brice, A., Morgan, K., Foroud, T.M., Kukull, W.A., Hannequin, D., Powell, J.F., Nalls, M.A., Ritchie, K., Lunetta, K.L., Kauwe, J.S., Boerwinkle, E., Riemenschneider, M., Boada, M., Hiltuenen, M., Martin, E.R., Schmidt, R., Rujescu, D., Wang, L.S., Dartigues, J.F., Mayeux, R., Tzourio, C., Hofman, A., Nothen, M.M., Graff, C., Psaty, B.M., Jones, L., Haines, J.L., Holmans, P.A., Lathrop, M., Pericak-Vance, M.A., Launer, L.J., Farrer, L.A., van Duijn, C.M., Van Broeckhoven, C., Moskvina, V., Seshadri, S., Williams, J., Schellenberg, G.D., Amouyel, P., Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat. Genet. 45 (2013), 1452–1458.
37. Leskov, K.S., Klokov, D.Y., Li, J., Kinsella, T.J., Boothman, D.A., Synthesis and functional analyses of nuclear clusterin, a cell death protein. J. Biol. Chem. 278 (2003), 11590–11600.
38. Licastro, F., Grimaldi, L.M., Bonafe, M., Martina, C., Olivieri, F., Cavallone, L., Giovanietti, S., Masliah, E., Franceschi, C., Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain. Neurobiol. Aging 24 (2003), 921–926.
39. May, P.C., Lampert-Etchells, M., Johnson, S.A., Poirier, J., Masters, J.N., Finch, C.E., Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat. Neuron 5 (1990), 831–839.
40. Mi, H., Muruganujan, A., Thomas, P.D., PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees. Nucleic Acids Res. 41:Database issue (2013), D377–D386.
41. Mishima, K., Inoue, H., Nishiyama, T., Mabuchi, Y., Amano, Y., Ide, F., Matsui, M., Yamada, H., Yamamoto, G., Tanaka, J., Yasuhara, R., Sakurai, T., Lee, M.C., Chiba, K., Sumimoto, H., Kawakami, Y., Matsuzaki, Y., Tsubota, K., Saito, I., Transplantation of side population cells restores the function of damaged exocrine glands through clusterin. Stem Cells 30 (2012), 1925–1937.
42. Morris, J.C., The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43 (1993), 2412–2414.
43. Nasole, E., Nicoletti, C., Yang, Z.J., Girelli, A., Rubini, A., Giuffreda, F., Di Tano, A., Camporesi, E., Bosco, G., Effects of alpha lipoic acid and its R+ enantiomer supplemented to hyperbaric oxygen therapy on interleukin-6, TNF-alpha and EGF production in chronic leg wound healing. J. Enzyme Inhib. Med. Chem. 29 (2014), 297–302.
44. Nilselid, A.M., Davidsson, P., Nagga, K., Andreasen, N., Fredman, P., Blennow, K., Clusterin in cerebrospinal fluid: analysis of carbohydrates and quantification of native and glycosylated forms. Neurochem. Int. 48 (2006), 718–728.
45. Oda, T., Wals, P., Osterburg, H.H., Johnson, S.A., Pasinetti, G.M., Morgan, T.E., Rozovsky, I., Stine, W.B., Snyder, S.W., Holzman, T.F., Krafft, G.A., Finch, C.E., Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stress. Exp. Neurol. 136 (1995), 22–31.
46. Price, A.L., Patterson, N.J., Plenge, R.M., Weinblatt, M.E., Shadick, N.A., Reich, D., Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38 (2006), 904–909.
47. Pucci, S., Mazzarelli, P., Sesti, F., Boothman, D.A., Spagnoli, L.G., Interleukin-6 affects cell death escaping mechanisms acting on Bax-Ku70-Clusterin interactions in human colon cancer progression. Cell Cycle 8 (2009), 473–481.
48. Quintanilla, R.A., Orellana, D.I., Gonzalez-Billault, C., Maccioni, R.B., Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway. Exp. Cell Res. 295 (2004), 245–257.
49. Schaefer, C.F., Anthony, K., Krupa, S., Buchoff, J., Day, M., Hannay, T., Buetow, K.H., PID: the pathway interaction database. Nucleic Acids Res. 37:Database issue (2009), D674–D679.
50. Schrijvers, E.M., Koudstaal, P.J., Hofman, A., Breteler, M.M., Plasma clusterin and the risk of Alzheimer disease. JAMA 305 (2011), 1322–1326.
51. Shaw, L.M., Vanderstichele, H., Knapik-Czajka, M., Clark, C.M., Aisen, P.S., Petersen, R.C., Blennow, K., Soares, H., Simon, A., Lewczuk, P., Dean, R., Siemers, E., Potter, W., Lee, V.M., Trojanowski, J.Q., Alzheimer's Disease Neuroimaging Initiative. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann. Neurol. 65 (2009), 403–413.
52. Sherry, S.T., Ward, M.H., Kholodov, M., Baker, J., Phan, L., Smigielski, E.M., Sirotkin, K., dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29 (2001), 308–311.
53. Skol, A.D., Scott, L.J., Abecasis, G.R., Boehnke, M., Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat. Genet. 38 (2006), 209–213.
54. Team, R.C. R: A Language and Environment for Statistical Computing. 2015, R Foundation for Statistical Computing, Vienna, Austria.
55. Thomas, P.D., Kejariwal, A., Guo, N., Mi, H., Campbell, M.J., Muruganujan, A., Lazareva-Ulitsky, B., Applications for protein sequence-function evolution data: mRNA/protein expression analysis and coding SNP scoring tools. Nucleic Acids Res. 34:Web Server issue (2006), W645–W650.
56. Toledo, J.B., Vanderstichele, H., Figurski, M., Aisen, P.S., Petersen, R.C., Weiner, M.W., Jack, C.R. Jr., Jagust, W., Decarli, C., Toga, A.W., Toledo, E., Xie, S.X., Lee, V.M., Trojanowski, J.Q., Shaw, L.M., Alzheimer's Disease Neuroimaging, I. Factors affecting Abeta plasma levels and their utility as biomarkers in ADNI. Acta Neuropathol. 122 (2011), 401–413.
57. Wang, K., Li, M., Hakonarson, H., ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res., 38, 2010, e164.
58. Wang, Q., Cao, W., Su, Q., Liu, Z., Zhang, L., Clusterin silencing inhibits proliferation and reduces invasion in human laryngeal squamous carcinoma cells. World J. Surg. Oncol., 12, 2014, 124.
59. Wilson, M.R., Yerbury, J.J., Poon, S., Potential roles of abundant extracellular chaperones in the control of amyloid formation and toxicity. Mol. Biosyst. 4 (2008), 42–52.
60. Wyatt, A.R., Yerbury, J.J., Berghofer, P., Greguric, I., Katsifis, A., Dobson, C.M., Wilson, M.R., Clusterin facilitates in vivo clearance of extracellular misfolded proteins. Cell Mol. Life Sci. 68 (2011), 3919–3931.